CHIMERIC ANTIGEN RECEPTORS CONTAINING GLYPICAN 2 BINDING DOMAINS
The present disclosure is directed to chimeric antigen receptors binding to Glypican 2, nucleic acids encoding the same, and cells expressing the same, and methods of using such cells to treat cancers that express or overexpress the Glypican 2 antigen.
Saved in:
Main Authors | , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
18.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present disclosure is directed to chimeric antigen receptors binding to Glypican 2, nucleic acids encoding the same, and cells expressing the same, and methods of using such cells to treat cancers that express or overexpress the Glypican 2 antigen. |
---|---|
AbstractList | The present disclosure is directed to chimeric antigen receptors binding to Glypican 2, nucleic acids encoding the same, and cells expressing the same, and methods of using such cells to treat cancers that express or overexpress the Glypican 2 antigen. |
Author | DIMITROV, Dimiter MARIS, John ZHU, ZHONGYU FOSTER, Jessica BARRETT, David HEITZENEDER, Sabine JELEV, Dontcho V MACKALL, Crystal BOSSE, Kristopher MAJZNER, Robbie |
Author_xml | – fullname: BARRETT, David – fullname: MACKALL, Crystal – fullname: JELEV, Dontcho V – fullname: HEITZENEDER, Sabine – fullname: MARIS, John – fullname: BOSSE, Kristopher – fullname: FOSTER, Jessica – fullname: DIMITROV, Dimiter – fullname: MAJZNER, Robbie – fullname: ZHU, ZHONGYU |
BookMark | eNrjYmDJy89L5WRwcPbw9HUN8nRWcPQL8XR39VMIcnV2DQjxDwpWcPb3C3H09PP0c1dw94kM8HR29FMwUnDy9HMBCbn4-wIlg3kYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBkZGRqbmZqbGjoTFxqgBj4i03 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2022257653A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2022257653A13 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 30 05:42:33 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2022257653A13 |
Notes | Application Number: US202017597580 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220818&DB=EPODOC&CC=US&NR=2022257653A1 |
ParticipantIDs | epo_espacenet_US2022257653A1 |
PublicationCentury | 2000 |
PublicationDate | 20220818 |
PublicationDateYYYYMMDD | 2022-08-18 |
PublicationDate_xml | – month: 08 year: 2022 text: 20220818 day: 18 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY The Children's Hospital of Philadelphia THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC |
RelatedCompanies_xml | – name: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC – name: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY – name: The Children's Hospital of Philadelphia |
Score | 3.413474 |
Snippet | The present disclosure is directed to chimeric antigen receptors binding to Glypican 2, nucleic acids encoding the same, and cells expressing the same, and... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | CHIMERIC ANTIGEN RECEPTORS CONTAINING GLYPICAN 2 BINDING DOMAINS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220818&DB=EPODOC&locale=&CC=US&NR=2022257653A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-J0SkDpW5F2bdkeirZptlVcWvoh82n0ayBIN1zFf99L2HRPe0tyEC4hl_tI7ncADyj-ulaZuZpbWqkaaJSq6AZleJZRPZt5ZmSF_G3BrUlqvMzMWQs-t7kwEif0R4IjokQVKO-NvK9X_0EsT_6tXD_mHzi0fBoltqdsvGNdFwhtiufaLAy8gCqU2mms8EjShG1t9h30lQ6EIS2Q9tmbK_JSVrtKZXQKhyHOVzdn0KrqDhzTbe21DhxNN0_e2NxI3_ocnunEl0UaicMTf8w4iRhlYRJEMaEBTxyf-3xMxq_voSjkSHTi-twTQ14wRWJ8AfcjltCJiqzM_1Y-T-NdvvuX0K6XdXUFpEBHxOyLNFFrYWhZORQ4WkOrNPJqMdCKrAu9fTNd7yffwInoitCpNuhBu_n6rm5R9zb5ndyyX9glgJ0 |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQGlb0XatXV7GLqln7qlpR8yn0rbdSBIN1zFf99L2HRPewt3EJKQy33k7ncA9yj-qlLquZwbykzW0CiV0Q3K8C6jetbzTMsKkW3BDDfRXqb6tAGfm1oYgRP6I8ARUaIKlPdavNfL_yCWKXIrVw_5B5IWT3Y8MKW1d6yqHKFNMkcDK_BNn0qUDpJIYqHgcdta7w7RV9p75Pi83Hh6G_G6lOW2UrGPYD_A-ar6GBpl1YYW3fRea8PBZP3ljcO19K1O4Jm6nmjSSIYs9hyLkdCiVhD7YUSoz-KhxzzmEGf8HvBGjkQlI4-ZnGT6E2RGp3BnWzF1ZVxK-rfzNIm21909g2a1qMpzIAU6InqXl4kac03JZn2Oo9U3ZlpezntKkV1AZ9dMl7vZt9By48k4HXvs9QoOOYuHUZVeB5r113d5jXq4zm_E8f0CBESDig |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CHIMERIC+ANTIGEN+RECEPTORS+CONTAINING+GLYPICAN+2+BINDING+DOMAINS&rft.inventor=BARRETT%2C+David&rft.inventor=MACKALL%2C+Crystal&rft.inventor=JELEV%2C+Dontcho+V&rft.inventor=HEITZENEDER%2C+Sabine&rft.inventor=MARIS%2C+John&rft.inventor=BOSSE%2C+Kristopher&rft.inventor=FOSTER%2C+Jessica&rft.inventor=DIMITROV%2C+Dimiter&rft.inventor=MAJZNER%2C+Robbie&rft.inventor=ZHU%2C+ZHONGYU&rft.date=2022-08-18&rft.externalDBID=A1&rft.externalDocID=US2022257653A1 |